News
According to a recent article,“Behçet's disease is rare, with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Eur ...
India's R&D sector is evolving significantly, driven by governmental support and strategic initiatives. The i3 Summit, ...
A biotech startup's substantial funding round signals growing interest in domestic production of critical medicine components.
Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ...
The "Ophthalmics Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of 344 ophthalmics ...
11d
Capital Brief on MSNLumos Diagnostics shares soar 155% after $487m deal
Lumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...
Detailed price information for Salarius Pharmaceuticals Inc (SLRX-Q) from The Globe and Mail including charting and trades.
In recent years, biomedical research is evolving rapidly by integrating large amounts of data from clinical investigations, laboratory experiments, internet of things and healthcare records.
The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institution with a National Cancer Institute-designated Cancer Center. JAX leverages a unique combination of research, ...
--Smartkem, which is seeking to change the world of electronics with a new class of transistor technology, today announced that it has entered into a preliminary Joint Development Agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results